Works matching DE "EDOXABAN"

Results: 129

Does Prophylactic Administration of Edoxaban Increase D-Dimer Levels after Total Hip Arthroplasty?

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 5, p. 678, doi. 10.3390/jcm8050678

By:

Kawai, Toshiyuki;
Kuroda, Yutaka;
Goto, Koji;
Matsuda, Shuichi

Publication type:

Article

For AF With Stable CAD, Edoxaban Alone Prevents More Adverse Outcomes Than Edoxaban Plus an Antiplatelet Agent.

Published in:: American Family Physician, 2025, v. 111, n. 5, p. 474
Publication type:: Article

Gallbladder hemorrhage during orally administered edoxaban therapy: a case report.

Published in:

2019

By:

Itagaki, Hideya;
Katuhiko, Suzuki

Publication type:

journal article

UBLED AF (Uninterrupted BLackpool EDoxaban vs Warfarin vs Rivaroxaban in Atrial Fibrillation/Flutter ablation) Study.

Published in:

JAFIB: Journal of Atrial Fibrillation, 2021, v. 14, n. 2, p. 1, doi. 10.4022/jafib.20200445

By:

Kumar, Narendra;
Elbanhawy, Noha;
Choudhury, Moinuddin;
Potluri, Rahul;
Chalil, Shajil;
Abozguia, Khalid

Publication type:

Article

Safety of The Direct Oral Anticoagulant Edoxaban for Atrial Fibrillation After Cardiac Surgery: Pilot Study.

Published in:

JAFIB: Journal of Atrial Fibrillation, 2016, v. 9, n. 3, p. 11, doi. 10.4022/jafib.1456

By:

Akira Sezai;
Shunji Osaka;
Hiroko Yaoita;
Munehito Arimoto;
Hiroaki Hata;
Masashi Tanaka

Publication type:

Article

Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model.

Published in:

PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0195122

By:

Lu, Genmin;
Pine, Polly;
Leeds, Janet M.;
DeGuzman, Francis;
Pratikhya, Pratikhya;
Lin, Joyce;
Malinowski, John;
Hollenbach, Stanley J.;
Curnutte, John T.;
Conley, Pamela B.

Publication type:

Article

Pharmacokinetics of anticoagulants apixaban, dabigatran, edoxaban and rivaroxaban in elderly Japanese patients with atrial fibrillation treated in one general hospital.

Published in:

Xenobiotica, 2019, v. 49, n. 9, p. 1001, doi. 10.1080/00498254.2018.1524188

By:

Ota, Miki;
Notsu, Yuki;
Shimizu, Makiko;
Yamazaki, Hiroshi;
Yamazaki-Nishioka, Miho;
Kogiku, Minoru;
Noda, Masayuki;
Endo, Sumio;
Takekawa, Mitsuru;
Kishi, Hirohisa

Publication type:

Article

Unsolved issues of the efficacy and safety of edoxaban.

Published in:

Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi, 2021, v. 25, n. 6, p. 460, doi. 10.5152/AnatolJCardiol.2021.81410

By:

Drabik, Leszek;
Undas, Anetta

Publication type:

Article

The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis.

Published in:

Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi, 2021, v. 25, n. 2, p. 77, doi. 10.14744/AnatolJCardiol.2020.18049

By:

Xiangwen Liang;
Wenchao Xie;
Zhihai Lin;
Ming Liu

Publication type:

Article

Edoxaban Monotherapy in Nonvalvular Atrial Fibrillation Patients with Coronary Artery Disease.

Published in:

Journal of Interventional Cardiology, 2022, v. 2022, p. 1, doi. 10.1155/2022/5905022

By:

Fukamachi, Daisuke;
Okumura, Yasuo;
Matsumoto, Naoya;
Tachibana, Eizo;
Oiwa, Koji;
Ichikawa, Makoto;
Haruta, Hironori;
Nomoto, Kazumiki;
Arima, Ken;
Hirayama, Atsushi

Publication type:

Article

A randomized comparison of two direct oral anticoagulants for patients undergoing cardiac ablation with a contemporary warfarin control arm.

Published in:

2021

By:

Yoshimoto, Issei;
Iriki, Yasuhisa;
Oketani, Naoya;
Okui, Hideki;
Ichiki, Hitoshi;
Maenosono, Ryuichi;
Namino, Fuminori;
Miyata, Masaaki;
Ohishi, Mitsuru

Publication type:

journal article

Direct Oral Anticoagulants Versus Traditional Anticoagulation in Cirrhotic Patients with Portal Vein Thrombosis: Updated Systematic Review.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2024, v. 30, p. 1, doi. 10.1177/10760296241303758

By:

Xiao, Xiulin;
Zhu, Wengen;
Dai, Qixin

Publication type:

Article

Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE Program.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2024, v. 30, p. 1, doi. 10.1177/10760296241260728

By:

Unverdorben, Martin;
Colonna, Paolo;
Jin, James;
Köhler, Sabine;
Santamaria, Amparo;
Saxena, Manish;
Borrow, Amanda;
Chen, Cathy;
von Heymann, Christian;
Vanassche, Thomas

Publication type:

Article

Challenges to Laboratory Monitoring of Direct Oral Anticoagulants.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2024, v. 30, p. 1, doi. 10.1177/10760296241241524

By:

Qiao, Jesse;
Tran, Minh-Ha

Publication type:

Article

Predictive Factors and Clinical Events Associated with Edoxaban Interruption and Heparin Bridging Strategy: EMIT-AF/VTE.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2023, v. 29, p. 1, doi. 10.1177/10760296231200223

By:

Santamaria, Amparo;
Chen, Cathy;
Colonna, Paolo;
von Heymann, Christian;
Saxena, Manish;
Vanassche, Thomas;
Jin, James;
Unverdorben, Martin

Publication type:

Article

Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2023, v. 29, p. 1, doi. 10.1177/10760296231180865

By:

Olivera, Pável;
Velásquez-Escandón, César;
Campoy, Desirée;
Flores, Katia;
Canals, Tania;
Johansson, Erik;
Herranz, María José;
Martínez, Laia;
Cerezo-Manchado, Juan José;
Salinas, Ramón

Publication type:

Article

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2022, v. 28, p. 1, doi. 10.1177/10760296221138297

By:

Mehrotra, Siddharth;
Hoppensteadt, Debra;
Jeske, Walter;
Siddiqui, Fakiha;
Iqbal, Omer;
Tafur, Alfonso;
Lewis, Bruce;
Jaradeh, Mark;
Kantarcioglu, Bulent;
Fareed, Jawed

Publication type:

Article

Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation.

Published in:

Clinical & Applied Thrombosis/Hemostasis, 2020, v. 26, p. 1, doi. 10.1177/1076029620948585

By:

Sokol, Juraj;
Nehaj, Frantisek;
Ivankova, Jela;
Mokan, Michal;
Lisa, Lenka;
Zolkova, Jana;
Vadelova, Lubica;
Mokan, Marian;
Stasko, Jan

Publication type:

Article

Design of Experiment Mediated Development of Stability Indicating High Performance Thin Layer Chromatography Method Invoking Failure Mode Effect Analysis Based Risk Assessment in Estimation of Edoxaban Tosylate Monohydrate.

Published in:

Indian Journal of Pharmaceutical Education & Research, 2022, v. 56, n. 2, p. 553, doi. 10.5530/ijper.56.2.78

By:

Mistry, Vrunda Balvantbhai;
Patel, Hitika Bharatbhai;
Dedhiya, Praful Pravinchandra;
Bodiwala, Kunjan Bharatbhai;
Lodha, Sandesh Rajmal;
Joshi, Shrikant Vijayrao;
Kalyankar, Gajanan Govindrao

Publication type:

Article

Population pharmacokinetics and pharmacodynamics of edoxaban in pediatric patients.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2025, v. 14, n. 1, p. 118, doi. 10.1002/psp4.13248

By:

Zou, Peng;
Atluri, Akhilesh;
Chang, Peter;
Goedecke, Michael;
Leil, Tarek A.

Publication type:

Article

Correction to "Physiologically‐based pharmacokinetic pharmacodynamic parent‐metabolite model of edoxaban to predict drug–drug‐disease interactions: M4 contribution".

Published in:: CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1279, doi. 10.1002/psp4.13187
Publication type:: Article

Physiologically‐based pharmacokinetic pharmacodynamic parent‐metabolite model of edoxaban to predict drug–drug‐disease interactions: M4 contribution.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 8, p. 1093, doi. 10.1002/psp4.12977

By:

Xu, Ruijuan;
Liu, Wenyuan;
Ge, Weihong;
He, Hua;
Jiang, Qing

Publication type:

Article

Edoxaban Exposure-Response Analysis and Clinical Utility Index Assessment in Patients With Symptomatic Deep-Vein Thrombosis or Pulmonary Embolism.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2016, v. 5, n. 4, p. 222, doi. 10.1002/psp4.12077

By:

Nyberg, J;
Karlsson, KE;
Jönsson, S;
Yin, OQP;
Miller, R;
Karlsson, MO;
Simonsson, USH

Publication type:

Article

SARS-CoV-2 triggered seizure complicated by fatal subdural hematoma under edoxaban and clopidogrel.

Published in:

2022

By:

Finsterer, Josef;
Korn, Maria

Publication type:

Case Study

Prolonged Secondary Stroke Prevention with Edoxaban: A Long-Term Follow-Up of the SATES Study.

Published in:

Brain Sciences (2076-3425), 2023, v. 13, n. 11, p. 1541, doi. 10.3390/brainsci13111541

By:

Scala, Irene;
Bellavia, Simone;
Rizzo, Pier Andrea;
Di Giovanni, Jacopo;
Monforte, Mauro;
Morosetti, Roberta;
Marca, Giacomo Della;
Pilato, Fabio;
Broccolini, Aldobrando;
Profice, Paolo;
Frisullo, Giovanni

Publication type:

Article

Prospective Observational Study of Safety of Early Treatment with Edoxaban in Patients with Ischemic Stroke and Atrial Fibrillation (SATES Study).

Published in:

Brain Sciences (2076-3425), 2021, v. 11, n. 1, p. 30, doi. 10.3390/brainsci11010030

By:

Frisullo, Giovanni;
Profice, Paolo;
Brunetti, Valerio;
Scala, Irene;
Bellavia, Simone;
Broccolini, Aldobrando;
Caliandro, Pietro;
Di Iorio, Riccardo;
Morosetti, Roberta;
Pilato, Fabio;
Laborante, Renzo;
Della Marca, Giacomo

Publication type:

Article

Edoxaban: A Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism.

Published in:

Cardiology & Therapy, 2016, v. 5, n. 1, p. 1, doi. 10.1007/s40119-016-0058-2

By:

Stacy, Zachary;
Call, William;
Hartmann, Aaron;
Peters, Golden;
Richter, Sara

Publication type:

Article

Bioequivalence and Pharmacokinetic Study of 2 Edoxaban Tablets in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1440, doi. 10.1002/cpdd.1156

By:

Liu, Lihua;
Li, Xin;
Liu, Yujie;
Xu, Bing;
Li, Yuan;
Yuan, Fang;
Zhang, Ping;
Tu, Shengqing;
Hu, Wenhui

Publication type:

Article

Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 666, doi. 10.1002/cpdd.1050

By:

Yin, Ophelia;
Kakkar, Tarundeep;
Duggal, Anil;
Kotsuma, Masakatsu;
Shi, Minggao;
Lanz, Hans;
Grosso, Michael A.

Publication type:

Article

Population Pharmacokinetics of Edoxaban in Japanese Atrial Fibrillation Patients With Severe Renal Impairment.

Published in:

Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 484, doi. 10.1002/cpdd.329

By:

Shimizu, Takako;
Tachibana, Masaya;
Kimura, Tetsuya;
Kumakura, Tomohiko;
Yoshihara, Kazutaka

Publication type:

Article

Effectiveness and safety of edoxaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies.

Published in:

Frontiers in Pharmacology, 2023, p. 01, doi. 10.3389/fphar.2023.1276491

By:

Alsultan, Mohammed M.;
Alahmari, Abdullah K.;
Mahmoud, Mansour A.;
Almalki, Ziyad S.;
Alzlaiq, Wafa;
Alqarni, Faisal;
Alsultan, Fahad;
Ahmed, Nehad Jaser;
Alenazi, Ahmed O.;
Scharf, Lucas;
Jianfei Guo, Jeff

Publication type:

Article

A universal anti‐Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation.

Published in:

British Journal of Haematology, 2021, v. 193, n. 6, p. 1203, doi. 10.1111/bjh.17470

By:

Willekens, Guido;
Studt, Jan‐Dirk;
Mendez, Adriana;
Alberio, Lorenzo;
Fontana, Pierre;
Wuillemin, Walter A.;
Schmidt, Adrian;
Graf, Lukas;
Gerber, Bernhard;
Bovet, Cedric;
Sauter, Thomas C.;
Nagler, Michael

Publication type:

Article

Andexanet alfa (ONDEXXYA® for Intravenous Injection 200 mg), a reversal agent for direct factor Xa inhibitors: pharmacological characteristics and clinical evidence.

Published in:

Folia Pharmacologica Japonica, 2023, v. 158, n. 1, p. 89, doi. 10.1254/fpj.22107

By:

Toshitaka Yajima;
Mitsuo Higashimori;
Chie Takata;
Toshikazu Sasabe

Publication type:

Article

Effect of Clarithromycin, a Strong CYP3A and P-glycoprotein Inhibitor, on the Pharmacokinetics of Edoxaban in Healthy Volunteers and the Evaluation of the Drug Interaction with Other Oral Factor Xa Inhibitors by a Microdose Cocktail Approach.

Published in:

Cardiovascular Drugs & Therapy, 2024, v. 38, n. 4, p. 747, doi. 10.1007/s10557-023-07443-2

By:

Lenard, Alexander;
Hermann, Simon A.;
Stoll, Felicitas;
Burhenne, Juergen;
Foerster, Kathrin I.;
Mikus, Gerd;
Meid, Andreas D.;
Haefeli, Walter E.;
Blank, Antje

Publication type:

Article

Direct Current Cardioversion in Atrial Fibrillation Patients on Edoxaban Therapy Versus Vitamin K Antagonists: a Real-world Propensity Score–Matched Study.

Published in:

Cardiovascular Drugs & Therapy, 2021, v. 35, n. 5, p. 1003, doi. 10.1007/s10557-020-07078-7

By:

Rago, Anna;
Papa, Andrea Antonio;
Attena, Emilio;
Parisi, Valentina;
Golino, Paolo;
Nigro, Gerardo;
Russo, Vincenzo

Publication type:

Article

Evaluation of acute thrombus regression effect of edoxaban for deep vein thrombosis in patients with cancer: a single-center prospective observational study.

Published in:

Heart & Vessels, 2024, v. 39, n. 11, p. 958, doi. 10.1007/s00380-024-02418-1

By:

Hisatake, Shinji;
Kiuchi, Shunsuke;
Dobashi, Shintaro;
Murakami, Yoshiki;
Ikeda, Takanori

Publication type:

Article

Association between plasma concentration of edoxaban determined by direct and indirect methods in Japanese patients with non-valvular atrial fibrillation (CVI ARO 7).

Published in:

Heart & Vessels, 2020, v. 35, n. 3, p. 409, doi. 10.1007/s00380-019-01501-2

By:

Suzuki, Shinya;
Morishima, Yoshiyuki;
Takita, Atsushi;
Otsuka, Takayuki;
Yagi, Naoharu;
Arita, Takuto;
Yamashita, Takeshi

Publication type:

Article

Responses of prothrombin time and activated partial thromboplastin time to edoxaban in Japanese patients with non-valvular atrial fibrillation: characteristics of representative reagents in Japan (CVI ARO 7).

Published in:

Heart & Vessels, 2019, v. 34, n. 12, p. 2011, doi. 10.1007/s00380-019-01438-6

By:

Suzuki, Shinya;
Morishima, Yoshiyuki;
Takita, Atsushi;
Yagi, Naoharu;
Otsuka, Takayuki;
Arita, Takuto;
Yamashita, Takeshi

Publication type:

Article

Edoxaban suppresses the progression of atrial fibrosis and atrial fibrillation in a canine congestive heart failure model.

Published in:

Heart & Vessels, 2019, v. 34, n. 8, p. 1381, doi. 10.1007/s00380-019-01377-2

By:

Tsujino, Yasushi;
Sakamoto, Tamotsu;
Kinoshita, Koshi;
Nakatani, Yosuke;
Yamaguchi, Yoshiaki;
Kataoka, Naoya;
Nishida, Kunihiro;
Kinugawa, Koichiro

Publication type:

Article

Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism in Patients With Active Cancer.

Published in:

In Vivo, 2021, v. 35, n. 5, p. 2747, doi. 10.21873/invivo.12559

By:

MISATO OGATA;
YUMI AMA;
TAKATSUGU OGATA;
MASAKI HIRABATAKE;
HISATERU YASUI;
HIRONAGA SATAKE

Publication type:

Article

Edoxaban improves atrial fibrillation and thromboembolism through regulation of the Wnt-β-induced PI3K/ATK-activated protein C system.

Published in:

Experimental & Therapeutic Medicine, 2019, v. 17, n. 5, p. 3509

By:

Shan, Xuefeng;
Liu, Zhiqiang;
Wulasihan, Muhuyati;
Ma, Songfeng

Publication type:

Article

Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44345-7

By:

Baldus, Stephan;
Beyer-Westendorf, Jan;
Möllmann, Helge;
Rottbauer, Wolfgang;
Beyerlein, Elisabeth;
Goette, Andreas

Publication type:

Article

Association between SLCO1B1 genetic polymorphisms and bleeding risk in patients treated with edoxaban.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43179-7

By:

Han, Ji Min;
Jang, Eun Jeong;
Yee, Jeong;
Song, Tae-Jin;
Kim, Dong-Hyeok;
Park, Junbeom;
Gwak, Hye Sun

Publication type:

Article

Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-44345-7

By:

Baldus, Stephan;
Beyer-Westendorf, Jan;
Möllmann, Helge;
Rottbauer, Wolfgang;
Beyerlein, Elisabeth;
Goette, Andreas

Publication type:

Article

Association between SLCO1B1 genetic polymorphisms and bleeding risk in patients treated with edoxaban.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43179-7

By:

Han, Ji Min;
Jang, Eun Jeong;
Yee, Jeong;
Song, Tae-Jin;
Kim, Dong-Hyeok;
Park, Junbeom;
Gwak, Hye Sun

Publication type:

Article

Edoxaban (Savaysa)--The Fourth New Oral Anticoagulant.

Published in:: JAMA: Journal of the American Medical Association, 2015, v. 314, n. 1, p. 76, doi. 10.1001/jama.2015.7098
Publication type:: Article

The clinical course of symptomatic deep vein thrombosis after 3 months of anticoagulant therapy using fondaparinux/edoxaban or fondaparinux/vitamin K antagonist.

Published in:

Therapeutics & Clinical Risk Management, 2018, v. 14, p. 377, doi. 10.2147/TCRM.S153517

By:

Shimizu, Kazuhiro;
Iiduka, Takuo;
Sato, Shuji;
Kiyokawa, Hajime;
Nakagami, Takahiro;
Mikamo, Hiroshi;
Kawazoe, Masayo;
Takahashi, Mao;
Noro, Mahito

Publication type:

Article

Comparative risk impact of edoxaban in the management of stroke and venous thromboembolism.

Published in:

2016

By:

Tellor, Katie B.;
van Tuyl, Joseph S.;
Armbruster, Anastasia L.

Publication type:

journal article

Secondary prevention in non-valvular atrial fibrillation patients: a practical approach with edoxaban.

Published in:

International Journal of Neuroscience, 2017, v. 127, n. 8, p. 716, doi. 10.1080/00207454.2016.1232256

By:

Masjuan, Jaime;
DeFelipe, Alicia

Publication type:

Article

Heparin-Calibrated Anti-Factor Xa Assay for the Measurement of Direct Anticoagulants such as Apixaban, Rivaroxaban, and Edoxaban.

Published in:

Clinical Laboratory, 2024, v. 70, n. 9, p. 1682, doi. 10.7754/Clin.Lab.2024.240314

By:

Hyo-Suk Ahn;
Hyojin Chae;
Yeongsic Kim;
Hey Kyung Lee;
Hyunjung Kim

Publication type:

Article